Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Deglutition Disorders × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Neoplasms 9 Polycystic Ovary Syndrome 8 Multiple Myeloma 4 Melanoma 4 Vomiting 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Skin Neoplasms 2 Sarcoma 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Obesity 2 Nausea 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Leukemia 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Diabetes Mellitus 2

Interventions

Radiotherapy 3 Cisplatin 3 Cryotherapy 2 Carboplatin 2 Brachytherapy 2 Acupuncture Therapy 2 tislelizumab 1 pembrolizumab 1 epigallocatechin gallate 1 durvalumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Tablets 1 Standard of Care 1 Respiratory Function Tests 1 Resistance Training 1 Range of Motion, Articular 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Pravastatin 1 Parenteral Nutrition 1 Paclitaxel 1 Nivolumab 1 Niacinamide 1 Musculoskeletal Manipulations 1 Lead 1 Immunotherapy 1 Hyaluronic Acid 1 Gastropexy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07217938 2026-03-03

TRADstat

Peter MacCallum Cancer Centre, Australia

Phase 2 Recruiting

Deglutition Disorders, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡